E-resources
Peer reviewed
Open access
-
Brudon, Alexandre; Legendre, Marie; Mageau, Arthur; Bermudez, Julien; Bonniaud, Philippe; Bouvry, Diane; Cadranel, Jacques; Cazes, Aurélie; Crestani, Bruno; Dégot, Tristan; Delestrain, Céline; Diesler, Rémi; Epaud, Ralph; Philippot, Quentin; Théou-Anton, Nathalie; Kannengiesser, Caroline; Ba, Ibrahima; Debray, Marie-Pierre; Fanen, Pascale; Manali, Efrosine; Papiris, Spyros; Nathan, Nadia; Amselem, Serge; Gondouin, Antoine; Guillaumot, Anne; Andréjak, Claire; Jouneau, Stephane; Beltramo, Guillaume; Uzunhan, Yurdagul; Galodé, François; Westeel, Virginie; Mehdaoui, Anas; Hirschi, Sandrine; Leroy, Sylvie; Marchand-Adam, Sylvain; Nunes, Hilario; Picard, Clément; Prévot, Grégoire; Reynaud-Gaubert, Martine; De Vuyst, Paul; Wemeau, Lidwine; Defossez, Gautier; Zalcman, Gérard; Cottin, Vincent; Borie, Raphael
The European respiratory journal, 05/2024, Volume: 63, Issue: 5Journal Article
Several rare surfactant-related gene (SRG) variants associated with interstitial lung disease are suspected to be associated with lung cancer, but data are missing. We aimed to study the epidemiology and phenotype of lung cancer in an international cohort of SRG variant carriers. We conducted a cross-sectional study of all adults with SRG variants in the OrphaLung network and compared lung cancer risk with telomere-related gene (TRG) variant carriers. We identified 99 SRG adult variant carriers ( (n=18), (n=31), (n=24), (n=14) and (n=12)), including 20 (20.2%) with lung cancer ( (n=7), (n=8), (n=3), (n=2) and (n=0)). Among SRG variant carriers, the odds of lung cancer was associated with age (OR 1.04, 95% CI 1.01-1.08), smoking (OR 20.7, 95% CI 6.60-76.2) and / variants (OR 3.97, 95% CI 1.39-13.2). Adenocarcinoma was the only histological type reported, with programmed death ligand-1 expression ≥1% in tumour cells in three samples. Cancer staging was localised (I/II) in eight (40%) individuals, locally advanced (III) in two (10%) and metastatic (IV) in 10 (50%). We found no somatic variant eligible for targeted therapy. Seven cancers were surgically removed, 10 received systemic therapy, and three received the best supportive care according to their stage and performance status. The median overall survival was 24 months, with stage I/II cancers showing better survival. We identified 233 TRG variant carriers. The comparative risk (subdistribution hazard ratio) for lung cancer in SRG patients TRG patients was 18.1 (95% CI 7.1-44.7). The high risk of lung cancer among SRG variant carriers suggests specific screening and diagnostic and therapeutic challenges. The benefit of regular computed tomography scan follow-up should be evaluated.
Author
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.